If nausea is severe or doesnt improve with home remedies, consult a doctor
Data Animal Data In pregnant rats given twice weekly subcutaneous doses of 0.02, 0.1, and 0.5 mg/kg tirzepatide (0.03-, 0.07-, and 0.5-fold the MRHD of 15 mg once weekly based on AUC) during organogenesis, increased incidences of external, visceral, and skeletal malformations, increased incidences of visceral and skeletal developmental variations, and decreased fetal weights coincided with pharmacologically-mediated reductions in maternal body weights and food consumption at 0.5 mg/kg
If you start with a drug which puts you at a greater probability of lean body mass loss and you have a preexisting history of musculoskeletal diseases, it puts you at greater risk of lower tolerance to exercise
The FDA recommends you switch to non-oral alternatives for a month after starting the medication and every time you go up in dose to be safe
For deeper coverage of how glycine interacts with tirzepatide at the molecular level, our tirzepatide glycine B12 compound guide breaks down the science in detail
No worrying about cold chain maintenance during long flights
